tm
Seeing Is Believing
tm
Seeing Is Believing
APRE is currently covered by 1 analysts with an average price target of $14.27. This is a potential upside of $12.82 (884.14%) from yesterday's end of day stock price of $1.45.
Aprea Therapeutics's activity chart (see below) currently has 32 price targets and 33 ratings on display. The stock rating distribution of APRE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 20.57 days.
Highest price target for APRE is $4, Lowest price target is $3.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 14-Jan-2025. First documented stock forecast 27-Oct-2019.
Currently out of the existing stock ratings of APRE, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
9 months 16 days ago
(14-Jan-2025)
0/6 (0%)
$15.86 (383.09%)
Buy
$11
$9.6 (685.71%)
$11
1 years 2 months 18 days ago
(12-Aug-2024)
0/3 (0%)
$7.7 (233.33%)
Hold
$80
$78.6 (5614.29%)
3 years 7 months 15 days ago
(15-Mar-2022)
1/4 (25%)
$40.2 (101.01%)
44
Hold
$40
$38.6 (2757.14%)
$80
3 years 7 months 15 days ago
(15-Mar-2022)
3/4 (75%)
$0.2 (0.50%)
21
Hold
$500
4 years 2 months 11 days ago
(19-Aug-2021)
2/2 (100%)
$47.6 (10.52%)
16
What is APRE (Aprea Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on APRE (Aprea Therapeutics) with a proven track record?
Which analyst has the current lower performing score on APRE (Aprea Therapeutics) with a proven track record?
Which analyst has the most public recommendations on APRE (Aprea Therapeutics)?
Which analyst is the currently most bullish on APRE (Aprea Therapeutics)?
Which analyst is the currently most reserved on APRE (Aprea Therapeutics)?
